Stell Virginia H, Norton H James, Smith Kevin S, Salo Jonathan C, White Richard L
Division of Surgical Oncology, Department of General Surgery, Carolinas Medical Center, Blumenthal Cancer Center, 1025 Morehead Medical Drive, Suite 600, Charlotte, NC 28204, USA.
Ann Surg Oncol. 2007 Feb;14(2):893-8. doi: 10.1245/s10434-006-9240-4. Epub 2006 Nov 21.
The staging of patients with primary melanoma is dependent on adequate sampling of the tumor thickness. Initial biopsies with a positive deep margin suggest inadequate sampling, potentially limiting accurate staging and affecting treatment decisions.
To determine the efficacy of shave biopsy to adequately sample the tumor, we retrospectively reviewed our pathology database for original pathology reports of primary melanomas accessioned between 01/01/04 and 6/30/05. The biopsies were evaluated by technique, the presence of tumor at the margins of the specimen, and specimen thickness.
We identified 240 cases of primary melanoma; 223/240 were analyzable. The specimens were divided by biopsy technique (excisional, n = 51; punch, n = 44; and shave, n = 128). Shave and punch specimens had a significantly higher percentage of positive margins than excisional specimens (50, 68, and 16%, respectively; P < 0.0001). Shave specimens had a significantly higher percentage of positive deep margins than punch or excisional specimens (22, 7, and 2%, respectively; P = 0.0009). For melanomas <or=1 mm, shave specimens had a significantly higher percentage of positive deep margins than punch or excisional specimens (17, 0, and 0%, respectively; P = 0.0014). There was a significant difference in specimen thickness (P = 0.0005), with shave specimens being the thinnest.
The presence of tumor at the lateral margin of punch biopsies is an expected result, since this method is often used to diagnose lesions with a large diameter. The presence of positive deep margins in 22% of shave biopsy specimens compromises the ability of this technique to properly stage patients.
原发性黑色素瘤患者的分期取决于对肿瘤厚度的充分采样。初次活检时深部切缘阳性提示采样不充分,这可能会限制准确分期并影响治疗决策。
为确定削除活检对肿瘤进行充分采样的效果,我们回顾性分析了病理数据库中2004年1月1日至2005年6月30日期间收录的原发性黑色素瘤的原始病理报告。通过活检技术、标本边缘肿瘤的存在情况以及标本厚度对活检进行评估。
我们共识别出240例原发性黑色素瘤病例;其中223例可进行分析。标本根据活检技术进行分类(切除活检,n = 51;钻孔活检,n = 44;削除活检,n = 128)。削除活检和钻孔活检标本的阳性切缘百分比显著高于切除活检标本(分别为50%、68%和16%;P < 0.0001)。削除活检标本的深部阳性切缘百分比显著高于钻孔活检或切除活检标本(分别为22%、7%和2%;P = 0.0009)。对于厚度≤1 mm的黑色素瘤,削除活检标本的深部阳性切缘百分比显著高于钻孔活检或切除活检标本(分别为17%、0%和0%;P = 0.0014)。标本厚度存在显著差异(P = 0.0005),削除活检标本最薄。
钻孔活检标本的外侧边缘出现肿瘤是预期结果,因为该方法常用于诊断直径较大的病变。22%的削除活检标本出现深部阳性切缘,这损害了该技术对患者进行准确分期的能力。